Hello, Guest
Login
Sign Up
 
 

Rockwell Medical, Inc. (NASDAQ:RMTI), NXP Semiconductors NV (NASDAQ:NXPI), and Cynosure, Inc. (NASDAQ:CYNO) Added to Growing Stock Report's NASDAQ Decliners Watch List

 
 
Repost This

New York, NY -- (SBWIRE) -- 03/19/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Rockwell Medical, Inc. (NASDAQ:RMTI), NXP Semiconductors NV (NASDAQ:NXPI), and Cynosure, Inc. (NASDAQ:CYNO).

Rockwell Medical, Inc. (NASDAQ:RMTI) an integrated biopharmaceutical company that engages in the manufacture, sale, and distribution of hemodialysis concentrates/dialysates targeting the end-stage renal disease, chronic kidney disease, and iron deficiency anemia in the United States and internationally closed down in its previous session (-4.81%) on 433,251 shares traded after Rockwell Medical Reported its 2012 Fourth Quarter and Full Year Results. Rockwell Medical, Inc. (NASDAQ:RMTI) is currently down (-62.15%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Rockwell Medical, Inc. (NASDAQ:RMTI)

NXP Semiconductors NV (NASDAQ:NXPI) a company that through its subsidiary, NXP B.V., provides mixed signal solutions and standard products worldwide closed down in its previous session (-4.77%) on 6,575,601 shares traded after the NFC Times reported over the weekend that Samsung (SSNLF) had elected to use NFC controllers made by Broadcom (BRCM) for its new Galaxy S4 smartphone, rather than NXP's NFC controllers. NXP Semiconductors NV (NASDAQ:NXPI) is currently down (-10.7%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about NXP Semiconductors NV (NASDAQ:NXPI)

Cynosure, Inc. (NASDAQ:CYNO) a company that develops, manufactures, and markets aesthetic treatment systems primarily to the dermatology, plastic surgery, and general medical markets closed down in its previous session (-4.75%) on 357,435 shares traded after reported that Cynosure is to Acquire Palomar Medical Technologies. Cynosure, Inc. (NASDAQ:CYNO) is currently down (-11.36%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Cynosure, Inc. (NASDAQ:CYNO)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com